67c9cae1aea28285e7e3d7d4c4307d214f79befe
Home.md
| ... | ... | @@ -294,12 +294,7 @@ PMBL panel, Desch 2020, 10 |
| 294 | 294 | |
| 295 | 295 | **Tier 1** - Genes can transition to Tier 1 only after additional studies have demonstrated the recurrence of mutations in the same entity. |
| 296 | 296 | |
| 297 | -### Additional Designations |
|
| 298 | - |
|
| 299 | -**aSHM** - Denotes genes as affected by aberrant somatic hypermutation (aSHM). Tier 1 and Tier 2 genes can have this designation, respectively abbreviated as *1-a* and *2-a*. For example, see [BCL7A](BCL7A). |
|
| 300 | - |
|
| 301 | -**Fail** - Some studies with large additions to Tier 2 lists have undergone manual review of the primary data. If the majority of mutations in a gene fail QC, the gene will be given the designation *2-F*. For example, see [MARK1](MARK1). |
|
| 302 | - |
|
| 297 | +**Tier 3** - Tier 3 is reserved for genes that were once nominated as a driver but have since been retired due to a lack of support in the original study nominating them. |
|
| 303 | 298 | |
| 304 | 299 | ## Other resources available for each gene |
| 305 | 300 |